BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q2 2024 Earnings Call Transcript August 5, 2024
BioCryst Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.0614, expectations were $-0.19.
Operator: Good day and welcome to the BioCryst Second Quarter 2024 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded....
